PTPA and neoplasm: Although PP2A normally acts as a tumor suppressor by dephosphorylating c-Myc, CIP2A maintains c-Myc phosphorylation and promotes its overexpression by binding PP2A and inhibiting its activity, which ultimately drives tumor growth [27,28].